
Results
4
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
4 companies
Medicalgorithmics
Market Cap: zł291.1m
Provides cardiac diagnostic solutions in Poland, the United States, and internationally.
MDG
zł29.70
7D
-1.0%
1Y
14.5%
Selvita
Market Cap: zł547.9m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.50
7D
-5.3%
1Y
-3.2%
Milton Essex Spólka Akcyjna
Market Cap: zł13.9m
Designs, develops, manufactures, and sells medical devices, instruments, and products in Poland.
MTN
zł0.90
7D
11.9%
1Y
37.7%
Tecnovatica
Market Cap: zł7.6m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
TEC
zł0.69
7D
-4.4%
1Y
81.1%